Long-Term Follow-up of Down Syndrome

โ† Back to Index (๐Ÿ“ˆ Development and Growth)

General Principles and Growth Monitoring

System-Specific Surveillance Protocol

Organ System Evaluation/Screening Modality Recommended Frequency
Cardiac Echocardiography In the newborn period or before 9 months of age; subsequent follow-up depends on findings.
Endocrine (Thyroid) Thyroid Stimulating Hormone (TSH) and Thyroxine (T4) At birth, 6 months, 12 months, and annually thereafter through childhood. Antithyroid antibodies may be tested in older children.
Audiology/ENT Audiologic evaluation Every 6 months until 3-4 years of age (or until reliable ear-specific results are obtained), then annually.
Ophthalmology Pediatric ophthalmologic evaluation By 1 year of age (or within the first 6 months), annually until age 5, biannually until age 13, and every 3 years thereafter.
Hematology Complete Blood Count (CBC) and Hemoglobin CBC with differential in the neonatal period; screen for leukemia twice in the first year; annual hemoglobin test through childhood.
Sleep / Pulmonary Polysomnography (Sleep Study) Baseline study to evaluate for obstructive sleep apnea (OSA) by 4 years of age, or earlier if symptomatic.
Dental Pediatric dental examination Initial visit at 1 year of age, followed by check-ups at least every 6 months to manage delayed eruption, malocclusion, and periodontal disease.

Neurodevelopmental and Behavioral Management

Musculoskeletal and Cervical Spine Surveillance

Gastrointestinal and Immunologic Monitoring

Transition to Adulthood and Genetic Counseling